Thursday, 26 October 2017

Endo International sues FDA on drug compounding policy

(Reuters) - Endo International Plc on Thursday filed a lawsuit against the U.S. Food and Drug Administration asking the court to declare the regulator's current bulk compounding norms unlawful.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)